Navigating the Evolving Treatment Paradigm for Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN)
Navigating the Evolving Treatment Paradigm for Myelodysplastic Syndromes (MDS) and Myeloproliferative Neoplasms (MPN) is organized by Prime Education, LLC.
Release Date: October 26, 2023
Expiration Date: October 25, 2024
Description:
From the integration of refined risk stratification schemas to the magnitude of emerging data for novel therapeutic agents, the clinical advances for the management of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) hold the potential to transform patient outcomes.
Catch all of the latest evidence in this webcast, featuring dynamic discussions from leading experts regarding the placement of emerging therapies into personalized treatment plans for patients with MDS and MPN, with a focus on federal, public, and government healthcare settings.
Learning Objectives:
• Assess the role of molecular, predictive, and prognostic factors in guiding treatment decisions for patients with hematologic malignancies
• Differentiate targeted agents and immunotherapies based on mechanism of action, new safety and efficacy data, and place in therapy
• Apply current evidence and guidelines for the diagnosis, treatment, and management of hematologic malignancies
• Employ interprofessional strategies for care coordination and referral to specialists for patients with hematologic malignancies